← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2011Last known activity
Sep 16, 2024
Timeline
1990s
- Jun 1, 1998
VistaGen Therapeutics, Inc.— Founded
2020s
- Dec 21, 2022
Pherin Pharmaceuticals, Inc.— Acquired
Drugs by trial phase (5 distinct, 14 trials)
Phase 3 (0 own, 2 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (13)
- NCT06615557Lead sponsorPhase 3Sep 16, 2024
- NCT06358651Lead sponsorPhase 3Mar 28, 2024
- NCT05280054Lead sponsorPhase 1Dec 23, 2021
- NCT05030350Study directorPhase 3Oct 1, 2021
- NCT05030350Lead sponsorPhase 3Oct 1, 2021
- NCT05011396Lead sponsorPhase 3Aug 30, 2021
- NCT04754802Lead sponsorPhase 3May 24, 2021
- NCT04404192Lead sponsorPhase 2Nov 30, 2020
- NCT04147949Lead sponsorPhase 2Jul 31, 2020
- NCT03583554CollaboratorPhase 1/Phase 2Jul 1, 2018
- NCT03078322Lead sponsorPhase 2Jun 1, 2017
- NCT01483846Lead sponsorPhase 1Dec 1, 2011
- NCT01483846Study directorPhase 1Dec 1, 2011
Details
- Founded
- South San Francisco, CA, US Jun 1, 1998
- Last known activity
- Sep 16, 2024